| Prashant P Vivek, MD | |
|
330 S Garden Way, Suite 300, Eugene, OR 97401-8176 | |
| (541) 334-3370 | |
| (541) 334-3372 |
| Full Name | Prashant P Vivek |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 24 Years |
| Location | 330 S Garden Way, Eugene, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164520870 | NPI | - | NPPES |
| 006392 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD27513 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Healthcare Resources Llc | 4486835477 | 129 |
News Archive
Researchers have discovered how an experimental drug is capable of completely eradicating human lymphoma in mice after just five doses. The study, led by researchers at Weill Cornell Medical College, sets the stage for testing the drug in clinical trials of diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, itself the seventh most frequently diagnosed cancer in the U.S.
At the 2010 ACC conference held in Atlanta, GA, six new studies based on the PAT™ (Peripheral Arterial Tone) signal focused on assessing cardiovascular risk by measuring and improving endothelial health. Of those, two studies from Japan focused on assessing cardiovascular risk in both high and low risk patient populations.
New data demonstrate that GlaxoSmithKline's cervical cancer candidate vaccine, CERVARIX provides significant protection for women against the four most common cancer- causing human papillomavirus types for nearly six and a half years, the longest duration of protection reported to date.
The Alzheimer's Foundation of America (AFA) is extremely pleased that the historic health reform signed into law by President Obama late this morning, after passing the U.S. House of Representatives on Sunday and the U.S. Senate in December, includes a number of provisions that are especially significant for AFA's constituents—and bode well for improving quality of life for individuals with Alzheimer's disease and related dementias, and their family caregivers. In particular, we are grateful that the final action addresses many of the practical and financial needs faced daily by this population, speaks to preventative issues and bolsters training of dementia care professionals.
› Verified 3 days ago
| Entity Name | Oregon Healthcare Resources Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982907572 PECOS PAC ID: 4486835477 Enrollment ID: O20110223001220 |
News Archive
Researchers have discovered how an experimental drug is capable of completely eradicating human lymphoma in mice after just five doses. The study, led by researchers at Weill Cornell Medical College, sets the stage for testing the drug in clinical trials of diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, itself the seventh most frequently diagnosed cancer in the U.S.
At the 2010 ACC conference held in Atlanta, GA, six new studies based on the PAT™ (Peripheral Arterial Tone) signal focused on assessing cardiovascular risk by measuring and improving endothelial health. Of those, two studies from Japan focused on assessing cardiovascular risk in both high and low risk patient populations.
New data demonstrate that GlaxoSmithKline's cervical cancer candidate vaccine, CERVARIX provides significant protection for women against the four most common cancer- causing human papillomavirus types for nearly six and a half years, the longest duration of protection reported to date.
The Alzheimer's Foundation of America (AFA) is extremely pleased that the historic health reform signed into law by President Obama late this morning, after passing the U.S. House of Representatives on Sunday and the U.S. Senate in December, includes a number of provisions that are especially significant for AFA's constituents—and bode well for improving quality of life for individuals with Alzheimer's disease and related dementias, and their family caregivers. In particular, we are grateful that the final action addresses many of the practical and financial needs faced daily by this population, speaks to preventative issues and bolsters training of dementia care professionals.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Prashant P Vivek, MD Po Box 1648, Eugene, OR 97440-1648 Ph: (541) 334-3370 | Prashant P Vivek, MD 330 S Garden Way, Suite 300, Eugene, OR 97401-8176 Ph: (541) 334-3370 |
News Archive
Researchers have discovered how an experimental drug is capable of completely eradicating human lymphoma in mice after just five doses. The study, led by researchers at Weill Cornell Medical College, sets the stage for testing the drug in clinical trials of diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, itself the seventh most frequently diagnosed cancer in the U.S.
At the 2010 ACC conference held in Atlanta, GA, six new studies based on the PAT™ (Peripheral Arterial Tone) signal focused on assessing cardiovascular risk by measuring and improving endothelial health. Of those, two studies from Japan focused on assessing cardiovascular risk in both high and low risk patient populations.
New data demonstrate that GlaxoSmithKline's cervical cancer candidate vaccine, CERVARIX provides significant protection for women against the four most common cancer- causing human papillomavirus types for nearly six and a half years, the longest duration of protection reported to date.
The Alzheimer's Foundation of America (AFA) is extremely pleased that the historic health reform signed into law by President Obama late this morning, after passing the U.S. House of Representatives on Sunday and the U.S. Senate in December, includes a number of provisions that are especially significant for AFA's constituents—and bode well for improving quality of life for individuals with Alzheimer's disease and related dementias, and their family caregivers. In particular, we are grateful that the final action addresses many of the practical and financial needs faced daily by this population, speaks to preventative issues and bolsters training of dementia care professionals.
› Verified 3 days ago
William David Tom, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 330 S Garden Way, Suite 300, Eugene, OR 97401 Phone: 541-334-3370 Fax: 541-334-3372 | |
Susan L Urben, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 330 S Garden Way, Ste 300, Eugene, OR 97401 Phone: 541-334-3370 Fax: 541-334-3372 | |
Dr. Kenneth Albert Springate, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2095 Broadview St, Eugene, OR 97405 Phone: 541-342-3140 | |
Dr. Grace X. Tan, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1200 Hilyard St Ste 620, Eugene, OR 97401 Phone: 458-205-6500 Fax: 458-205-6453 | |
Dr. George Wallace Johansen, M.M. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1200 Hilyard St, Suite S-200, Eugene, OR 97401 Phone: 541-685-1755 | |
Nathan P Christensen, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1200 Hilyard St, Suite 620, Eugene, OR 97401 Phone: 458-205-6500 |